## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-20T12:30:35.856Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Journal Club: Medicine" developer_entity: "Peripheral Brain, LLC" bundle_id: "com.peripheralbrain.journalclub" app_store_id: "512153051" google_play_id: "com.journal.journalclub" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: true market_region: "US" platforms: "iOS & Android" app_last_updated: "2023-10-03" report_date: "2026-05-20" last_verified: "2026-05-20" report_version: "1.8.3" total_reviews: 166 overall_rating: 4.27 sentiment: "Frustrated" sentiment_score: 35 confidence: "high" confidence_score: 0.55 top_praise_theme: "Concise summaries of landmark clinical trials provide efficient reference for medical rounds" top_complaint_theme: "Lack of content updates since the latest release leaves the library feeling abandoned" top_request_theme: "Continuous expansion of the trial library to include the latest medical research" review_sample_size: 49 total_review_count: 49 analyzed_review_count: 49 data_age_days: 0 momentum_velocity: "zombie" intelligence_version: 3 nemesis: "Read by QxMD" competitor_count: 6 tags: ["medical", "paid", "frustrated sentiment", "mobile app", "app review", "app analysis", "medical", "students,", "residents,"] canonical_url: "https://marlvel.ai/intel-report/medical/com-peripheralbrain-journalclub" license: "CC-BY-NC 4.0" content_version: "v2" --- # Journal Club: Medicine App Audit ## TL;DR {#tldr} - **Category**: Medical · Paid - **Signal**: Rating 4.27 · Sentiment Frustrated - **Recent focus**: Lack of content updates since the latest release leaves the library feeling abandoned (top complaint) · Concise summaries of landmark clinical trials provide efficient reference for medical rounds (top praise) · Continuous expansion of the trial library to include the latest medical research (top request) > **TL;DR:** Journal Club: Medicine is a medical app by Peripheral Brain, LLC, rated 4.27/5 by 166 users, with Frustrated user sentiment (35/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Journal Club: Medicine faces Frustrated user sentiment (4.27/5 from 166 reviews), with lack of content updates since the latest release leaves the library feeling abandoned as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.27/5 (166 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Peripheral Brain, LLC | | **Pricing** | Paid | | **Platforms** | iOS & Android | | **Confidence** | High (0.55/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Peripheral Brain, LLC - **Category:** Medical - **Target Audience:** Medical students, residents, and internal medicine physicians requiring rapid access to landmark clinical trials. - **Platforms:** iOS & Android - **Version Audited:** 1.8.3 - **Audit Date:** 2026-05-20 - **Signal Count:** 49 reviews analyzed - **Confidence:** High (0.55/1.0) - **App Store ID (iOS):** 512153051 - **Bundle ID:** com.peripheralbrain.journalclub - **Google Play ID:** com.journal.journalclub - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-20 - **Short Description:** Journal Club is an research & academic activity at academic organisations. ## Executive Snapshot **What it is:** Journal Club: Medicine is a reference app for medical professionals that provides PICO-structured summaries of landmark clinical trials on iOS. **Why users hire it:** Clinicians hire this app to quickly digest landmark medical research during rotations, saving time compared to reading full-length journal articles. ## App DNA (Features & Intent) - **[Differentiator] PICO-structured summaries:** Distills medical research into standardized bottom lines, major points, and study design elements * *User Intent:* Users want to quickly find relevant content or features. - **[Standard] Offline content sync:** Downloads new article summaries for access without an active internet connection * *User Intent:* Users want uninterrupted access without internet dependency. ## Market Position {#market-position} The app holds a #24 Paid rank in the US Medical category, but the lack of updates since 2019 suggests the current ranking is driven by legacy brand awareness rather than active growth. ## Monetization Strategy - **Model:** Paid - **Tiers:** One-time purchase at $6.99 USD - **Price:** iOS: $6.99 - **Analysis:** Paid model anchored at $6.99, targeting professionals who prioritize time-saving clinical research summaries. ## 🔴 User Sentiment (High Confidence: 49 of 49 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.27/5 - **Platform Split:** iOS 4.3/5 (166 ratings) - **Overall Sentiment:** Frustrated - **Note:** The 4.27/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **Concise summaries of landmark clinical trials provide efficient reference for medical rounds** ### Top Complaints (Impact Areas) - **Lack of content updates since the latest release leaves the library feeling abandoned** ### Top Requests (What Users Want) - **Continuous expansion of the trial library to include the latest medical research** ## SWOT Analysis {#swot} **Core Strengths:** - PICO-structured format provides high-utility clinical efficiency for trainees - Offline-first architecture ensures reliability in hospital environments **Critical Frictions:** - Stale content library creates a high churn risk among professional users - Opaque billing complaints erode trust in the $6.99 purchase **Growth Levers:** - Automated AI synthesis could replace manual curation bottlenecks - Institutional partnerships could unlock full-text access to compete with QxMD **Market Threats:** - OpenEvidence AI-driven synthesis outpaces manual update cadence - Read by QxMD institutional integration renders summary-only tools obsolete ## Recent Changes (v2 → v3) {#recent-changes} The app remains in a state of total development inactivity, with the competitive analysis now explicitly framing its manual curation model as obsolete against AI-driven and institutional-integrated rivals. **Overall trend**: Declining **Compared at**: 2026-05-20 ### High-impact changes - **[Shifted] Formalization of 'Zombie' Status** (positioning) — Development momentum shifted from 'abandoned' to 'zombie', with the report confirming no updates since August 2019 (1512 days average between updates). - **[Added] New Competitive Threats** (swot) — Added specific threats: OpenEvidence (AI-driven synthesis) and Read by QxMD (institutional integration), replacing generic fraud concerns. ### Medium-impact changes - **[Removed] Feature Set Reduction** (features) — Features 'Advanced Filtering' and 'Favorites/Sharing' were removed from the key features list, narrowing the scope to only PICO summaries and offline sync. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Journal Club: Medicine vs Read by QxMD — Head to Head - **[Read by QxMD](https://marlvel.ai/intel-report/medical/read-by-qxmd)** by WebMD: This is the direct market leader for medical journal discovery and article curation, mirroring the target app's core value proposition of distilling research for clinicians. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Integrates institutional library access to unlock full-text PDFs directly within the mobile interface - Provides personalized journal feeds based on specific medical specialties and clinical interests - Offers a seamless discovery engine for landmark trials that exceeds the target's manual curation - **Where Journal Club: Medicine wins:** - ✅ Physician-written summaries provide a more digestible, high-level 'CliffsNotes' experience for time-constrained clinicians - ✅ Focused editorial voice offers a more curated, less overwhelming experience than broad-spectrum discovery tools - **Where Read by QxMD wins:** - ❌ Deep integration with institutional subscriptions provides immediate access to full-text research, not just summaries - ❌ Automated, personalized feed algorithms ensure clinicians see relevant updates without manual curation bottlenecks - **Verdict:** The target app must pivot toward institutional partnerships or automated discovery to compete with the scale of QxMD's full-text access. ### Contenders (Strong Challengers) - **[UpToDate](https://marlvel.ai/intel-report/medical/uptodate)** by UpToDate, Inc. [Moat: High]: The gold standard for clinical decision support, serving as the primary alternative for clinicians seeking evidence-based research. - Provides comprehensive, peer-reviewed clinical guidance rather than just article summaries - Functions as a primary clinical decision support tool used at the point of care - **[Medscape](https://marlvel.ai/intel-report/medical/medscape)** by WebMD [Moat: Medium]: A massive, multi-functional medical platform that includes news, drug references, and journal summaries. - Combines journal summaries with essential clinical tools like drug interaction checkers and medical calculators - Maintains a massive, active community and news feed that keeps users returning daily ### Peers (What They Do Better) - **[MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator)** by MD Aware, LLC: While focused on calculators, it occupies the same 'essential clinical utility' space for the same target audience. - Hyper-focused utility that solves specific clinical math problems at the point of care - High-frequency usage patterns driven by the necessity of clinical decision support tools - **[Figure 1 - Medical Cases](https://marlvel.ai/intel-report/medical/figure-1-medical-cases)** by Figure 1, Inc.: Focuses on visual, case-based learning which serves as an adjacent educational medium for the same medical audience. - Leverages crowdsourced medical imagery and case discussions to drive peer-to-peer learning - Visual-first interface provides a more engaging, social experience than text-heavy journal summaries ### New Kids on the Block (What's Innovative) - **[OpenEvidence](https://marlvel.ai/intel-report/medical/com-openevidence)** by OpenEvidence Inc.: An aggressive, AI-driven entrant that has shipped 28 updates in six months, signaling a rapid innovation cycle. ## What's New - **Latest (v1.0, 2 years ago):** Initial app launch. ## App Momentum (Zombie) {#momentum} - No major feature updates since 2019. - Maintenance-mode status limits new user conversion. > **Cadence:** 2 total versions · 0 majors in last 6 months · 960 days since last update · 1512 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Journal Club: Medicine is a challenged medical app that is a paid app. With a 4.27/5 rating from 166 reviews, it faces significant user friction. > **Bottom Line:** The app provides high-utility clinical summaries, but the lack of content updates since 2019 renders it obsolete against modern AI-driven competitors, so the PM must prioritize a content-refresh pipeline to prevent total user attrition. **Best for:** Medical students, residents, and internal medicine physicians requiring rapid access to landmark clinical trials. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Audit content pipeline to resume trial additions because stale data is the #1 complaint → restore user trust — *Sentiment analysis shows high-frequency complaints regarding lack of updates since 2019.* _(trade-off: deprioritize Pause all UI/UX feature work until the content library is refreshed.)_ ### Feature Gaps vs Competitors - Institutional full-text PDF access (available in Read by QxMD) - Automated personalized journal feeds (available in Read by QxMD) ### Outlook: Declining The medical reference market is shifting toward automated, real-time evidence synthesis, leaving static, manually-curated apps like this one increasingly exposed. Without a pivot to automated updates or institutional partnerships, the app will continue to lose relevance to competitors like OpenEvidence and QxMD. - 🔴 The lack of content updates since 2019 causes a sustained negative sentiment trend, which will accelerate churn as users migrate to more current alternatives. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.27/5 | | Total Reviews | 166 | | Sentiment | Frustrated (35/100) | | Confidence | High | | Pricing Model | Paid | | Platforms | iOS & Android | | Key Features | 2 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Journal Club: Medicine** (this app) | 4.27/5 | Frustrated | Peripheral Brain, LLC | | [OpenEvidence](https://marlvel.ai/intel-report/medical/com-openevidence) | 4.9/5 | N/A | OpenEvidence Inc. | | [UpToDate](https://marlvel.ai/intel-report/medical/uptodate) | 4.3/5 | N/A | UpToDate, Inc. | | [Read by QxMD](https://marlvel.ai/intel-report/medical/read-by-qxmd) | 4.8/5 | N/A | WebMD | | [Medscape](https://marlvel.ai/intel-report/medical/medscape) | 3.7/5 | N/A | WebMD | | [MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) | 4.9/5 | N/A | MD Aware, LLC | ## Company Profile - **Developer:** Peripheral Brain, LLC - **Website:** [https://journalclubapp.com](https://journalclubapp.com) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/journal-club-medicine/id512153051?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.journal.journalclub&hl=en&gl=us) - **Dev Site:** [Official Website](https://journalclubapp.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*OpenEvidence*](https://marlvel.ai/intel-report/medical/com-openevidence) (OpenEvidence Inc.) — 4.9/5 Rating | N/A Sentiment - [*UpToDate*](https://marlvel.ai/intel-report/medical/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | N/A Sentiment - [*Read by QxMD*](https://marlvel.ai/intel-report/medical/read-by-qxmd) (WebMD) — 4.8/5 Rating | N/A Sentiment - [*Medscape*](https://marlvel.ai/intel-report/medical/medscape) (WebMD) — 3.7/5 Rating | N/A Sentiment - [*MDCalc Medical Calculator*](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) (MD Aware, LLC) — 4.9/5 Rating | N/A Sentiment - [*Figure 1 - Medical Cases*](https://marlvel.ai/intel-report/medical/figure-1-medical-cases) (Figure 1, Inc.) — 4.7/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 49 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-peripheralbrain-journalclub) Data licensed for AI Agent attribution under CC-BY-NC 4.0.